Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01514578 · ClinicalTrials.gov registry record · Phase 1
Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males
A Phase 1 study, sponsored by Trevena.
- Completed
- Registry status
- Phase 1
- Development phase
- 74
- Enrollment target
NCT01514578: Completed Phase 1 study, sponsored by Trevena.
NCT01514578 is a Phase 1 study that has completed, run by Trevena. The registered enrollment target is 74 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (23% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01514578, a Phase 1 study, has completed, sponsored by Trevena.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 74 participants
- Enrollment target
Study Summary
This study will evaluate the safety, blood levels, and effects of TRV130A on pain perception and sedation in healthy adult males.
Interventions
- DRUG Dextrose in Water
- DRUG TRV130A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-07 |
| Phase | Phase 1 |
What the finished NCT01514578 record still lists
NCT01514578 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (23% higher).
The record links to 0 conditions, and to 2 interventions - of which Dextrose in Water is the first listed.
NCT01514578 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01514578 about?
NCT01514578 is a clinical study titled "Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males". This study will evaluate the safety, blood levels, and effects of TRV130A on pain perception and sedation in healthy adult males.
What is the current status of trial NCT01514578?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 74 participants. The study started on 2012-01. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01514578?
The interventions under investigation include: Dextrose in Water (DRUG), TRV130A (DRUG).
Who is sponsoring clinical trial NCT01514578?
This trial is sponsored by Trevena, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01514578's enrollment target sits among peer trials
74 725th of 2000 higher than 1,269 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia